Anavex Life Sciences Corp (AVXL)

[Good Ole Bill]

Jesse:

Thanks for compiling the questions for the meeting.

As I said in a previous post, I hope Dr. Sabbagh can be used more in future presentations.

If Dr. Sabbagh is in the meeting next week, it would be helpful if you could direct the below question to him:

“Dr. Sabbagh, in yesterday’s interview with Nancy Keach of Bright Focus Foundation, you were asked by an attendee about pricing for Blarcamesine. You responded briefly that this was something to be concerned about in the future (perhaps years). This has led to speculation that this comment may have indicated that the delay would also apply to Anavex’s future revenues. Could you add more color to your response? There are many who believe this has let to a negative drag on the company’s outlook since yesterday.”

Thanks in advance for your consideration.

Bill